Journal of Liver

Advances in hepatology

CO-ORGANIZED EVENT: 5^th World Congress on Hepatitis & Liver Diseases & 2^nd International Conference on Pancreatic Cancer & Liver Diseases

August 10-12, 2017 London, UK

Maxwell M Chait

Columbia University, USA

Scientific Tracks Abstracts: J Liver

Abstract:

The field of hepatology has had major advances in the evaluation and management of liver disease. The burden of liver disease worldwide depends essentially on the incidence of cirrhosis and hepatocellular carcinoma. The major factors causing cirrhosis are alcoholic liver disease (ALD), hepatitis B and C and nonalcoholic liver disease (NAFLD). Effective therapies for hepatitis B and C have been developed that continue to evolve with remarkable success. ALD remains a major health problem and NAFLD has become a health problem of epidemic proportions. Abstinence from alcohol and reduction in obesity are the major preventative strategies for these illnesses. Approaches continue to be developed to manage the complications of cirrhosis and hepatocellular carcinoma. Liver transplantation has evolved to a standard therapy for end-stage liver disease. Reducing the burden of liver disease through prevention, cure and treatment of complications is now possible.

Biography :

Maxwell M Chait is a Fellow of several prestigious organizations, including the American College of Physicians, American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a practicing Gastroenterologist on the Faculty of the Columbia University College of Physicians and Surgeons. He has authored numerous publications and serves on the editorial boards of several journals including the World Journal of Gastrointestinal Endoscopy and the Journal of Liver Disease and Transplantation Biology.